tm
Seeing Is Believing
tm
Seeing Is Believing
FUSN is currently covered by 6 analysts with an average price target of $21.76. This is a potential upside of $0.21 (0.97%) from yesterday's end of day stock price of $21.55.
Fusion Pharmaceuticals 's activity chart (see below) currently has 7 price targets and 24 ratings on display. The stock rating distribution of FUSN is 80% BUY and 20% HOLD.
Analysts average stock forecasts to be materialized ratio is 58.33% with an average time for these price targets to be met of 253 days.
Highest price target for FUSN is $16, Lowest price target is $11, average price target is $13.8.
Most recent stock forecast was given by YUAN ZHI from B. RILEY on 20-Mar-2024. First documented stock forecast 21-Jul-2020.
Currently out of the existing stock ratings of FUSN, 12 are a BUY (80%), 3 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$13
$-8.55 (-39.68%)
$13
11 months 12 days ago
(20-Mar-2024)
3/4 (75%)
$-8.09 (-38.36%)
287
Hold
$16
$-5.55 (-25.75%)
$16
11 months 12 days ago
(20-Mar-2024)
1/2 (50%)
$-5.09 (-24.13%)
15
Hold
$11
$-10.55 (-48.96%)
$10
11 months 13 days ago
(19-Mar-2024)
1/2 (50%)
$-10.18 (-48.06%)
496
Buy
$13
$-8.55 (-39.68%)
$13
1 years 1 months 6 days ago
(26-Jan-2024)
2/3 (66.67%)
$2.11 (19.38%)
131
Buy
$16
$-5.55 (-25.75%)
$15
1 years 1 months 27 days ago
(05-Jan-2024)
4/4 (100%)
$7.65 (91.62%)
143
What is FUSN (Fusion Pharmaceuticals ) average time for price targets to be met?
Which analyst has the current highest performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?
Which analyst has the current lower performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?
Which analyst has the most public recommendations on FUSN (Fusion Pharmaceuticals )?
Which analyst is the currently most bullish on FUSN (Fusion Pharmaceuticals )?
Which analyst is the currently most reserved on FUSN (Fusion Pharmaceuticals )?
